Skip to main content
main-content

20.10.2018 | Case Report | Ausgabe 1/2019

International Journal of Diabetes in Developing Countries 1/2019

Fibrocalculous pancreatic diabetes with hemorrhagic pericardial effusion in a female—a rare case report

Zeitschrift:
International Journal of Diabetes in Developing Countries > Ausgabe 1/2019
Autoren:
Vineeta Singh, Mohit Singh Tandon

Abstract

Fibrocalculous pancreatic diabetes (FCPD) is a unique form of diabetes due to non-alcoholic chronic pancreatitis peculiar to tropical countries. The hallmark features are younger age of onset pain abdomen and presence of pancreatic calculi. Though etiology remains unclear but on long-term follow-up, patient may develop microvascular and macrovascular complication. Chances of progression to malignancy are also high which carries poor prognosis. We present a case of a 36-year-old female presenting with recurrent abdominal pain, diabetes and chronic calcific pancreatitis. She was diagnosed to have FCPD based on her findings. She was managed with insulin, pancreatic enzyme supplementation and analgesics for pain relief. Due to her intractable pain poorly responding to medical management, she underwent Roux-en-Y pancreaticojejunostomy but later developed massive pericardial effusion hemorrhagic in nature with pleural effusion and ascitis. Analysis showed high possibility of adenocarcinoma though the primary focus could not be confirmed as the patient developed sepsis and unfortunately succumbed to her illness. Though FCPD is a rare entity, it is important to rule out chronic calcific pancreatitis as underlying etiology in all patients of diabetes presenting with recurrent pain abdomen and also to periodically screen FCPD patients for pancreatic malignancy. This helps to prevent progression to complications by an early medical intervention. Surgical intervention may be considered an option in case of failure of medical management, though data of its usefulness is very rare.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2019

International Journal of Diabetes in Developing Countries 1/2019 Zur Ausgabe
  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Sie können e.Med Allgemeinmedizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.